FY2025 EPS Forecast for Trulieve Cannabis Boosted by Analyst

Trulieve Cannabis Corp. (TSE:TRU) – Equities researchers at Cormark boosted their FY2025 earnings per share estimates for shares of Trulieve Cannabis in a research note issued to investors on Monday, March 3rd. Cormark analyst J. Pytlak now expects that the company will post earnings of ($0.18) per share for the year, up from their previous estimate of ($0.36). Cormark has a “Moderate Buy” rating on the stock. Cormark also issued estimates for Trulieve Cannabis’ FY2026 earnings at $0.11 EPS.

A number of other research firms also recently issued reports on TRU. Craig Hallum upgraded Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th. Atb Cap Markets raised shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th.

Trulieve Cannabis Price Performance

Insider Activity

In related news, Senior Officer Wes Getman bought 9,500 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average cost of C$7.02 per share, with a total value of C$66,702.35.

About Trulieve Cannabis

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.